{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:04:13Z","timestamp":1772111053061,"version":"3.50.1"},"reference-count":24,"publisher":"American Diabetes Association","issue":"11","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,11,1]]},"abstract":"<jats:p>OBJECTIVE\u2014In this study, we evaluated the efficacy of sibutramine in combination with hypoglycemic drugs in obese type 2 diabetic women whose glucose levels were poorly regulated.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014Female patients with type 2 diabetes, poorly controlled glucose levels, and HbA1c &amp;gt;8% were randomly assigned to one of two groups. In addition to their prescribed hypoglycemic agents (maximum doses of sulfonylureas and metformin), one group (n = 30) received a placebo twice daily for 6 months and the other (n = 30) received sibutramine 10 mg b.i.d. for the same period.<\/jats:p>\n               <jats:p>RESULTS\u2014One patient in the sibutramine group was excluded during the study period because of hypertension; thus, a total of 29 data sets were analyzed for this group. In the placebo group, five patients had to be excluded because of low treatment efficacy, leaving a total of 25 who completed the study. Comparing the changes that occurred over 6 months in the sibutramine and placebo groups, the former showed significantly greater reductions in fasting blood glucose (P &amp;lt; 0.0001), second-hour postprandial blood glucose (P &amp;lt; 0.0001), insulin resistance (P &amp;lt; 0.0001), waist circumference (P &amp;lt; 0.0001), BMI (P &amp;lt; 0.0001), HbA1c (P &amp;lt; 0.0001), diastolic blood pressure, pulse rate, uric acid levels, and all elements of the lipid profile except HDL cholesterol and apolipoprotein A1.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014The addition of sibutramine to oral hypoglycemic therapy resulted in significant weight loss and improvement in metabolic parameters in this patient group. Sibutramine is an effective adjunct to oral hypoglycemic therapy in obese women with type 2 diabetes.<\/jats:p>","DOI":"10.2337\/diacare.24.11.1957","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T22:51:27Z","timestamp":1173135087000},"page":"1957-1960","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":70,"title":["Effects of Sibutramine in Obese Female Subjects With Type 2 Diabetes and Poor Blood Glucose Control"],"prefix":"10.2337","volume":"24","author":[{"given":"Adnan","family":"Gokcel","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Baskent University, Adana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Karakose","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Baskent University, Adana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eda Melek","family":"Ertorer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Baskent University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nedret","family":"Tanaci","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Baskent University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan Bascil","family":"Tutuncu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Baskent University, Adana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilgun","family":"Guvener","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Baskent University, Adana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031216361956900_R1","doi-asserted-by":"crossref","unstructured":"Maggio CA, Pi-Sunyer FX: The prevention and treatment of obesity: application to type 2 diabetes. Diabetes Care\u200820:1744\u20131766, 1997","DOI":"10.2337\/diacare.20.11.1744"},{"key":"2022031216361956900_R2","unstructured":"Albu J, Konnarides C, Pi-Sunyer X: Weight control: metabolic and cardiovascular effects. Diabetes Rev\u20083:335\u2013347, 1995"},{"key":"2022031216361956900_R3","doi-asserted-by":"crossref","unstructured":"Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D: Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med\u2008147:1749\u20131753, 1987","DOI":"10.1001\/archinte.147.10.1749"},{"key":"2022031216361956900_R4","doi-asserted-by":"crossref","unstructured":"Lean ME, Powrie JK, Anderson AS, Garthwaite PH: Obesity, weight loss and prognosis in type 2 diabetes. Diabetes Med\u20087:228\u2013233, 1990","DOI":"10.1111\/j.1464-5491.1990.tb01375.x"},{"key":"2022031216361956900_R5","doi-asserted-by":"crossref","unstructured":"Close EJ, Wiles PG, Lockton JA, Walmsley D, Oldham J, Wales JK: Diabetic diets and nutritional recommendations: what happens in real life? Diabet Med\u20089:181\u2013188, 1992","DOI":"10.1111\/j.1464-5491.1992.tb01756.x"},{"key":"2022031216361956900_R6","doi-asserted-by":"crossref","unstructured":"Manning RM, Jung RT, Leese GP, Newton RW: The comparison of four weight reduction strategies aimed at overweight diabetic patients. Diabet Med\u200812:409\u2013415, 1995","DOI":"10.1111\/j.1464-5491.1995.tb00504.x"},{"key":"2022031216361956900_R7","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet\u2008352:854\u2013865, 1998","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"2022031216361956900_R8","doi-asserted-by":"crossref","unstructured":"Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycemia with macrovascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ\u2008321:405\u2013412, 2000","DOI":"10.1136\/bmj.321.7258.405"},{"key":"2022031216361956900_R9","unstructured":"Pyo\u0308ra\u0308la\u0308 K, Pedersen TR, Kjekshus J: The effect of cholesterol lowering with simvastatin on coronary artery diseases in diabetic patients with coronary artery disease (Abstract). Diabetes\u200844(Suppl. 1):35A, 1995"},{"key":"2022031216361956900_R10","doi-asserted-by":"crossref","unstructured":"Willey KA, Molyneaux LM, Yue DK: Obese patients with type 2 diabetes poorly controlled by insulin and metformin: effects of adjunctive dexfenfluramine therapy on glycaemic control. Diabet Med\u200811:701\u2013704, 1994","DOI":"10.1111\/j.1464-5491.1994.tb00336.x"},{"key":"2022031216361956900_R11","doi-asserted-by":"crossref","unstructured":"O\u2019Kane M, Wiles PG, Wales JK: Fluoxetine in the treatment of obese type 2 diabetic patients. Diabet Med\u200811:105\u2013110, 1994","DOI":"10.1111\/j.1464-5491.1994.tb00238.x"},{"key":"2022031216361956900_R12","doi-asserted-by":"crossref","unstructured":"Daubresse JC, Kolanowski J, Krzentowski G, Kutnowski M, Scheen A, Van Gaal L: Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study. Obes Res\u20084:391\u2013396, 1996","DOI":"10.1002\/j.1550-8528.1996.tb00247.x"},{"key":"2022031216361956900_R13","doi-asserted-by":"crossref","unstructured":"McNeely W, Goa KL: Sibutramine: a review of its contribution to the management of obesity. Drugs\u200856:1093\u20131124, 1998","DOI":"10.2165\/00003495-199856060-00019"},{"key":"2022031216361956900_R14","doi-asserted-by":"crossref","unstructured":"Day C, Bailey CJ: Effect of antiobesity agent sibutramine in obese-diabetic ob\/ob mice. Int J Obes Relat Metab Disord\u200822:619\u2013623, 1998","DOI":"10.1038\/sj.ijo.0800636"},{"key":"2022031216361956900_R15","unstructured":"Gokcel A, Gumurdulu Y, Karakose H, Karademir BM, Anarat R: Effects of sibutramine on leptin levels in nondieting obese women (Abstract). Int J Obes Relat Metab Disord\u200824(Suppl. 1):S171, 2000"},{"key":"2022031216361956900_R16","unstructured":"Kelley DE: Effects of weight loss on glucose homeostasis in NIDDM. Diabetes Rev\u20083:366\u2013377, 1995"},{"key":"2022031216361956900_R17","unstructured":"Schneider SH, Morgado A: Effects of fitness and physical training on carbohydrate metabolism and associated cardiovascular risk factors in patients with diabetes. Diabetes Rev\u20083:378\u2013407, 1995"},{"key":"2022031216361956900_R18","doi-asserted-by":"crossref","unstructured":"Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP, Sibutramine\/Diabetes Clinical Study Group: Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diab Obes Metab\u20082:175\u2013187, 2000","DOI":"10.1046\/j.1463-1326.2000.00081.x"},{"key":"2022031216361956900_R19","doi-asserted-by":"crossref","unstructured":"Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J: Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study. Diab Obes Metab\u20082:105\u2013112, 2000","DOI":"10.1046\/j.1463-1326.2000.00071.x"},{"key":"2022031216361956900_R20","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med\u2008329:977\u2013986, 1993","DOI":"10.1056\/NEJM199309303291401"},{"key":"2022031216361956900_R21","doi-asserted-by":"crossref","unstructured":"Klein R: Hyperglycemia and microvascular and macrovascular disease in diabetes (Review). Diabetes Care\u200818:258\u2013268, 1995","DOI":"10.2337\/diacare.18.2.258"},{"key":"2022031216361956900_R22","doi-asserted-by":"crossref","unstructured":"Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ: Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol\u200873:460\u2013468, 1994","DOI":"10.1016\/0002-9149(94)90676-9"},{"key":"2022031216361956900_R23","doi-asserted-by":"crossref","unstructured":"Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E: Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med\u2008106:179\u2013184, 1999","DOI":"10.1016\/S0002-9343(98)00411-2"},{"key":"2022031216361956900_R24","doi-asserted-by":"crossref","unstructured":"Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P: Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study. Int J Obes Relat Metab Disord\u200822:32\u201338, 1998","DOI":"10.1038\/sj.ijo.0800540"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/24\/11\/1957\/643454\/dc1101001957.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/24\/11\/1957\/643454\/dc1101001957.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T17:08:45Z","timestamp":1647104925000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/24\/11\/1957\/24848\/Effects-of-Sibutramine-in-Obese-Female-Subjects"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.24.11.1957","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11,1]]}}}